These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36438502)

  • 1. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling.
    Zhang Y; Cao Y; Zheng R; Xiong Z; Zhu Z; Gao F; Man W; Duan Y; Lin J; Zhang X; Wu D; Jiang M; Zhang X; Li C; Gu X; Fan Y; Sun D
    Theranostics; 2022; 12(17):7250-7266. PubMed ID: 36438502
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
    Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.
    Humeres C; Shinde AV; Tuleta I; Hernandez SC; Hanna A; Huang S; Venugopal H; Aguilan JT; Conway SJ; Sidoli S; Frangogiannis NG
    Circ Res; 2024 Jul; 135(3):453-469. PubMed ID: 38899461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway.
    Shen C; Yang S; Wu N; Jian W; Du T; Chu H; Du W
    Mol Cell Endocrinol; 2024 Oct; 592():112315. PubMed ID: 38878954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
    Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure.
    Yue X; Yang X; Lin X; Yang T; Yi X; Dai Y; Guo J; Li T; Shi J; Wei L; Fan GC; Chen C; Chang J
    Cell Death Dis; 2014 Jun; 5(6):e1284. PubMed ID: 24901055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.
    Peng T; Liu M; Hu L; Guo D; Wang D; Qi B; Ren G; Hu C; Zhang F; Chun HJ; Song L; Hu J; Li Y
    Biol Direct; 2022 Nov; 17(1):32. PubMed ID: 36384975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.
    Wu H; Li GN; Xie J; Li R; Chen QH; Chen JZ; Wei ZH; Kang LN; Xu B
    BMC Cardiovasc Disord; 2016 Jan; 16():5. PubMed ID: 26750922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy.
    Zheng D; Zhang Y; Hu Y; Guan J; Xu L; Xiao W; Zhong Q; Ren C; Lu J; Liang J; Hou J
    FEBS J; 2019 May; 286(9):1645-1655. PubMed ID: 30748104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted cardiac fibroblast BCAA catabolism contributes to diabetic cardiomyopathy via a periostin/NAP1L2/SIRT3 axis.
    Lu QB; Fu X; Liu Y; Wang ZC; Liu SY; Li YC; Sun HJ
    Cell Mol Biol Lett; 2023 Nov; 28(1):93. PubMed ID: 37993768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methyltransferase-1 inactivation of androgen receptor axis triggers homocysteine induced cardiac fibroblast autophagy in diabetic cardiac fibrosis.
    Tao H; Shi P; Xuan HY; Ding XS
    Arch Biochem Biophys; 2020 Oct; 692():108521. PubMed ID: 32800775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
    Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
    Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3.
    Tong J; Fu Y; Xu X; Fan S; Sun H; Liang Y; Xu K; Yuan Z; Ge Y
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2747-56. PubMed ID: 24667864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes.
    Hutchinson KR; Lord CK; West TA; Stewart JA
    PLoS One; 2013; 8(8):e72080. PubMed ID: 23991045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
    Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
    Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
    Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.